These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 20674645

  • 1. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening.
    Greenhough S, Medine CN, Hay DC.
    Toxicology; 2010 Dec 30; 278(3):250-5. PubMed ID: 20674645
    [Abstract] [Full Text] [Related]

  • 2. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.
    Nakamura N, Saeki K, Mitsumoto M, Matsuyama S, Nishio M, Saeki K, Hasegawa M, Miyagawa Y, Ohkita H, Kiyokawa N, Toyoda M, Akutsu H, Umezawa A, Yuo A.
    Cell Reprogram; 2012 Apr 30; 14(2):171-85. PubMed ID: 22384928
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Robust generation of hepatocyte-like cells from human embryonic stem cell populations.
    Medine CN, Lucendo-Villarin B, Zhou W, West CC, Hay DC.
    J Vis Exp; 2011 Oct 26; (56):e2969. PubMed ID: 22064456
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    Medine CN, Lucendo-Villarin B, Zhou W, West CC, Hay DC.
    ; 2008 Oct 26. PubMed ID: 23658988
    [Abstract] [Full Text] [Related]

  • 10. Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening.
    Takayama K, Mizuguchi H.
    Drug Metab Pharmacokinet; 2017 Feb 26; 32(1):12-20. PubMed ID: 28012798
    [Abstract] [Full Text] [Related]

  • 11. The application of human embryonic stem cell technologies to drug discovery.
    Sartipy P, Björquist P, Strehl R, Hyllner J.
    Drug Discov Today; 2007 Sep 26; 12(17-18):688-99. PubMed ID: 17826681
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human embryonic stem cells and liver diseases: from basic research to future clinical application.
    Wang Z, Lu H, Wang YC, Cong XQ.
    J Dig Dis; 2008 Feb 26; 9(1):14-9. PubMed ID: 18251789
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Three-dimensional cultured liver-on-a-Chip with mature hepatocyte-like cells derived from human pluripotent stem cells.
    Kamei KI, Yoshioka M, Terada S, Tokunaga Y, Chen Y.
    Biomed Microdevices; 2019 Jul 15; 21(3):73. PubMed ID: 31304567
    [Abstract] [Full Text] [Related]

  • 17. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening.
    Rana P, Anson B, Engle S, Will Y.
    Toxicol Sci; 2012 Nov 15; 130(1):117-31. PubMed ID: 22843568
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multi-component hydrogel fibers for liver tissue engineering.
    Du C, Narayanan K, Leong MF, Wan AC.
    Biomaterials; 2014 Jul 15; 35(23):6006-14. PubMed ID: 24780169
    [Abstract] [Full Text] [Related]

  • 20. Human pluripotent stem cells in drug discovery and predictive toxicology.
    Laustriat D, Gide J, Peschanski M.
    Biochem Soc Trans; 2010 Aug 15; 38(4):1051-7. PubMed ID: 20659002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.